
News
Jingyin Pharmaceutical submitted a listing application to the Hong Kong Stock Exchange, with joint sponsors Goldman Sachs, Haitong International, and HSBC

Jingyin Pharmaceutical submitted a listing application to the Hong Kong Stock Exchange, with joint sponsors Goldman Sachs, Haitong International, and HSBC